Cleared Traditional

K223135 - AblatePal Radiofrequency Ablation System

K223135 is the FDA 510(k) clearance for AblatePal Radiofrequency Ablation System by Compal Electronics, Inc.. It is a Class 2 General & Plastic Surgery device (product code GEI) cleared through the Traditional 510(k) pathway after a 270-day FDA review.

K223135 · Compal Electronics, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
270d
Days
Class 2
Risk

K223135 is an FDA 510(k) clearance for the AblatePal Radiofrequency Ablation System. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Compal Electronics, Inc. (Taipei City, TW). The FDA issued a Cleared decision on June 30, 2023 after a review of 270 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Compal Electronics, Inc. devices

Submission Details

510(k) Number K223135 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 03, 2022
Decision Date June 30, 2023
Days to Decision 270 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
155d slower than avg
Panel avg: 115d · This submission: 270d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 1118
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K223135.
Eblator Device
K231126 · E Surgical, LLC · Aug 2023
The InMode System with the Morpheus8 Applicators
K231790 · Inmode , Ltd. · Jul 2023
VYBE RF Electrosurgical System
K230968 · ShenB Co., Ltd. · Jul 2023
ARIS¿ COBLATION¿ Turbinate Reduction Wand (72290113)
K230914 · ArthroCare Corporation · Jun 2023
Tixel® 2 System
K223033 · Novoxel , Ltd. · Jun 2023
da Vinci E-200 Electrosurgical Generator
K231212 · Intuitive Surgical · Jun 2023